Skin Irritation

13 registered clinical trials studyying Skin Irritation.

Status	Trial	Sponsor	Phase
Completed	HRIPT Study to Evaluate the Irritation and Allergenic Potential of Medical-grade Norway Spruce (Picea Abies) R NCT06810856	Repolar Pharmaceuticals Oy	N/A
Completed	A Skin Irritation Assessment of Once-Weekly Corplex™ Donepezil Transdermal Delivery System NCT03397862	Corium, Inc.	Phase 1
Completed	Effect of Vitamin D After Application With Valchlor NCT02968446	University Hospitals Cleveland Medical Center	EARLY_Phase 1
Withdrawn	Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicyla NCT02400320	GlaxoSmithKline	Phase 4
Unknown	Evaluation of Effectiveness and Mildness of Whole-natural Hand-wash Formulations NCT02645110	Mother's Choice Ltd	N/A
Unknown	A 21-Day Topical Safety Study of Diltiazem Hydrochloride Using a Cumulative Irritant Patch Test Design NCT01821274	Ventrus Biosciences, Inc	Phase 1
Completed	Patch Test Skin Irritation/Sensitization of Cetaphil Restoraderm Skin Restoring Body Wash NCT01892410	Galderma R&D	N/A
Completed	Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser NCT01888887	Galderma R&D	N/A
Completed	Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Dermacontrol Oil Control Moisturizer SP NCT01887808	Galderma R&D	N/A
Completed	Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50 NCT01887860	Galderma R&D	N/A
Completed	Efficacy and Safety of Biocellulose Sheet Containing Anti-hyperpigmentation Agent ("Biocellulose Mask", "Farho NCT01806831	Chulalongkorn University	N/A
Completed	Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test NCT01892657	Galderma R&D	Phase 4
Completed	Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing Lotion NCT01892423	Galderma R&D	N/A